In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
We are very excited to launch our new website! Please take a few moments to click around and explore...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...